Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.

Saved in:
Bibliographic Details
Title: Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Authors: Funayama E; Department of Pharmacology, Showa University Graduate School of Pharmacy, Tokyo, Japan; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan., Hosonuma M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa University Graduate School of Medicine, Tokyo, Japan., Tajima K; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Isobe J; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan., Baba Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Murayama M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University Graduate School of Medicine, Tokyo, Japan., Narikawa Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University Graduate School of Medicine, Tokyo, Japan., Toyoda H; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Orthopedic Surgery, Showa University Graduate School of Medicine, Tokyo, Japan., Tsurui T; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa University Graduate School of Medicine, Tokyo, Japan., Maruyama Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Showa University Graduate School of Medicine, Tokyo, Japan., Sasaki A; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Surgery, Toho University Ohashi Medical Center., Amari Y; Division of Clinical Pharmacology, Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Otolaryngology, Showa University Fujigaoka Hospital, Yokohama, Japan., Yamazaki Y; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Toxicology, Showa University Graduate School of Pharmacy, Tokyo, Japan., Nakashima R; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Uchiyama J; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Nakano R; Department of Physiology, Showa University Graduate School of Pharmacy, Tokyo, Japan., Shida M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Sasaki A; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan., Udaka Y; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan., Oguchi T; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan., Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Tsuji M; Pharmacological Research Center, Showa University, Tokyo, Japan., Kiuchi Y; Pharmacological Research Center, Showa University, Tokyo, Japan; Department of Pharmacology, Showa University Graduate School of Medicine, Tokyo, Japan., Kim YG; Department of Microbiology, School of Pharmacy, Kitasato University, Tokyo, Japan., Wada S; Division of Medical Oncology, Department of Medicine, Showa University Graduate School of Medicine, Tokyo, Japan; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa University Graduate School of Medicine, Tokyo, Japan., Akiyama M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Nobe K; Department of Pharmacology, Showa University Graduate School of Pharmacy, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Yoshimura K; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa University Graduate School of Medicine, Tokyo, Japan. Electronic address: kyoshim1@med.showa-u.ac.jp.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2025 Jan; Vol. 182, pp. 117749. Date of Electronic Publication: 2024 Dec 23.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1950-6007
DOI:10.1016/j.biopha.2024.117749